Biosimilars, Brain Myths, Orphan Drugs, and Ebola

Share:

Listens: 0

Stanford Center for Law and the Biosciences Podcast Series

Miscellaneous


Hank Greely, Patti Zettler, Dmitry Karshtedt, and Stephanie Bair discuss new developments related to the Biosimilars Act and FDA's orphan drug program, the policy implications of brain myths, and the current Ebola crisis.